Chargement en cours...
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
More than 2,000,000 individuals worldwide have had coronavirus 2019 disease infection (COVID-19), yet there is no effective medical therapy. Multiple off-label and investigational drugs, such as chloroquine and hydroxychloroquine, have gained broad interest due to positive pre-clinical data and are...
Enregistré dans:
| Publié dans: | Eur Heart J Acute Cardiovasc Care |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7235441/ https://ncbi.nlm.nih.gov/pubmed/32372695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2048872620922784 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|